Allan Kyoshi Fukuyama is categorized under Noncommercial Biotechnical Research in Edmonds, WA and active since 1993.
Allan Kyoshi Fukuyama was established in 1993, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Noncommercial Biotechnical Research business, which does work in the B2B market, and is classified as a Noncommercial Biotechnical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Allan Kyoshi Fukuyama at the company’s single location by writing to 7019 157th St Sw, Edmonds, Washington WA 98026 or by phoning (425) 745-3349. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Allan Kyoshi Fukuyama |
| Contact Person: | Allan Kyoshi Fukuyama |
| Address: | 7019 157th St Sw, Edmonds, Washington 98026 |
| Phone Number: | (425) 745-3349 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1993 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Noncommercial Biotechnical Research |
| SIC Code: | 8733 |
| NAICS Code: | 541720 |
| Share This Business: |
Allan Kyoshi Fukuyama was started in 1993 to provide professional Noncommercial Biotechnical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Allan Kyoshi Fukuyama for inquiries that concern Allan Kyoshi Fukuyama by calling the company number (425) 745-3349, as your correspondence is most welcome. Additionally, the physical location of the single location of Allan Kyoshi Fukuyama can be found at the coordinates 47.856615,-122.328196 as well as the street address 7019 157th St Sw in Edmonds, Washington 98026.
For its online presence, you may visit Allan Kyoshi Fukuyama’s website at and engage with its social media outlets through on Twitter and on Facebook.